Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Dementia and GSK3B[original query] |
|---|
| Pharmacogenomics for the treatment of dementia. Annals of medicine 2002 34 (5): 357-79. Cacabelos Ram |
| Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. Annals of neurology 2007 Aug 62 (2): 145-53. Goris An, Williams-Gray Caroline H, Clark Graeme R, Foltynie Thomas, Lewis Simon J G, Brown Joanne, Ban Maria, Spillantini Maria G, Compston Alastair, Burn David J, Chinnery Patrick F, Barker Roger A, Sawcer Stephen |
| Association of GSK3B with Alzheimer disease and frontotemporal dementia. Archives of neurology 2008 Oct 65 (10): 1368-74. Schaffer Barbara A J, Bertram Lars, Miller Bruce L, Mullin Kristina, Weintraub Sandra, Johnson Nancy, Bigio Eileen H, Mesulam Marsel, Wiedau-Pazos Martina, Jackson George R, Cummings Jeffrey L, Cantor Rita M, Levey Allan I, Tanzi Rudolph E, Geschwind Daniel |
| Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer's disease. Journal of the neurological sciences 2016 Nov 370 162-166. Stefano Porcelli, Concetta Crisafulli, Luigi Donato, Marco Calabrò, Antonis Politis, Ioannis Liappas, Diego Albani, Anna Rita Atti, Raffaele Salfi, Ilaria Raimondi, Gianluigi Forloni, George N Papadimitriou, Diana De Ronchi, Alessandro Serret |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: